Mortality predictors in ST-elevated myocardial infarction patients undergoing coronary artery bypass grafting

Ugur Filizcan1, Erol Kurc, Sebnem Cetemen

  • 1Department of Cardiovascular Surgery, Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Center, Istanbul, Turkey. ugurfilizcan@yahoo.com

Angiology
|May 14, 2010
PubMed

Insights

For patients needing emergency coronary artery bypass grafting (CABG) due to ST-elevated myocardial infarction (STEMI), age, high cardiac troponin levels, and intra-aortic balloon pump use predict in-hospital mortality.

Area of Science:

  • Cardiology
  • Cardiac Surgery

Background:

  • Coronary artery bypass grafting (CABG) use in primary treatment for ST-elevated myocardial infarction (STEMI) remains a subject of debate.
  • Identifying mortality predictors in STEMI patients undergoing primary CABG is crucial for risk stratification and management.

Purpose of the Study:

  • To evaluate predictors of in-hospital mortality in patients undergoing primary CABG for STEMI.
  • To identify demographic, preoperative, intraoperative, and postoperative factors associated with mortality.

Main Methods:

  • Retrospective analysis of 150 STEMI patients who underwent primary CABG between January 2003 and January 2008.
  • Comparison of survivors and nonsurvivors using Cox regression and multivariate analysis.

Main Results:

  • In-hospital mortality rate was 22% (36 out of 150 patients).
  • Initial Cox regression identified age, cardiogenic shock, elevated cardiac troponin, preoperative intra-aortic balloon counterpulsation (IABP), prior myocardial infarction, and percutaneous coronary intervention as predictors.
  • Multivariate analysis confirmed age, preoperative cardiac troponin levels, and preoperative IABP use as independent predictors of in-hospital mortality.

Conclusions:

  • Age, preoperative cardiac troponin levels, and preoperative IABP use are significant predictors of in-hospital mortality in STEMI patients undergoing primary CABG.
  • These factors should be considered in the risk assessment and management of this patient population.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...